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Abstract
Molecular-receptor-targeted imaging of folate receptor positive oral carcinoma cells using
folic-acid-conjugated fluorescent Au25 nanoclusters (Au NCs) is reported. Highly fluorescent
Au25 clusters were synthesized by controlled reduction of Au+ ions, stabilized in bovine serum
albumin (BSA), using a green-chemical reducing agent, ascorbic acid (vitamin-C). For
targeted-imaging-based detection of cancer cells, the clusters were conjugated with folic
acid (FA) through amide linkage with the BSA shell. The bioconjugated clusters show excellent
stability over a wide range of pH from 4 to 14 and fluorescence efficiency of ∼5.7% at pH 7.4
in phosphate buffer saline (PBS), indicating effective protection of nanoclusters by serum
albumin during the bioconjugation reaction and cell–cluster interaction. The nanoclusters were
characterized for their physico-chemical properties, toxicity and cancer targeting efficacy in
vitro. X-ray photoelectron spectroscopy (XPS) suggests binding energies correlating to metal
Au 4f7/2 ∼ 83.97 eV and Au 4f5/2 ∼ 87.768 eV. Transmission electron microscopy and atomic
force microscopy revealed the formation of individual nanoclusters of size ∼1 nm and protein
cluster aggregates of size ∼8 nm. Photoluminescence studies show bright fluorescence with
peak maximum at ∼674 nm with the spectral profile covering the near-infrared (NIR) region,
making it possible to image clusters at the 700–800 nm emission window where the tissue
absorption of light is minimum. The cell viability and reactive oxygen toxicity studies indicate
the non-toxic nature of the Au clusters up to relatively higher concentrations of 500 μg ml−1.
Receptor-targeted cancer detection using Au clusters is demonstrated on FR+ve oral squamous
cell carcinoma (KB) and breast adenocarcinoma cell MCF-7, where the FA-conjugated Au25
clusters were found internalized in significantly higher concentrations compared to the negative
control cell lines. This study demonstrates the potential of using non-toxic fluorescent Au
nanoclusters for the targeted imaging of cancer.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Targeted imaging of cancer by simple yet high-resolution
optical and chemical methods has gathered momentum in
3 Author to whom any correspondence should be addressed.
recent times [1, 2]. Fluorescent quantum dot (QD)-based
optical imaging of cells has been a focus of researchers during
the past few years, owing to their unique optical, electronic
and physico-chemical characteristics [3, 4]. Although QDs
have numerous advantages over conventional organic dyes
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and fluorescent proteins such as intense luminescence, high
molar extinction coefficient, resistance to photo-bleaching
and broad excitation with narrow emission bands ideal for
high contrast optical imaging of biological systems [5] the
inherent compositional toxicity prevailing in most of the
QDs limit their practical application potential, particularly
in clinical scenarios [6]. In this context, it is important
to develop alternative biocompatible luminescent non-toxic
nanobioprobes for high contrast optical imaging.
Molecular clusters of plasmonic nanocrystals, particularly
gold (Au) and silver (Ag), are a new class of colloidal
fluorescent clusters that can find possible applications in
medical imaging [7]. Compared to large-sized nanoparticles
(10–100 nm) Au clusters consisting of a magic number of
atoms (Aun , where n = 18, 21, 25, 28, 32 or 39), show no
surface plasmon resonance but exhibit vis–NIR fluorescence
owing to the formation of molecular-type HOMO–LUMO
bandgap opening as well as electronic transitions at sub-
nanometer sizes smaller than the Fermi wavelength (i.e.
<1 nm) [8]. Optical absorption spectroscopy of Au28 clusters
with core diameters of ∼0.9 nm show an energy bandgap of
∼1.3 eV, which is much higher than the average energy of
bulk phonons, ∼10 mV, and therefore radiative recombination
of e–h pairs is competent with photon-assisted non-radiative
relaxation. However, due to the stringent size sensitivity of
such quantum mechanical properties, it was relatively difficult
to synthesize and stabilize atomic clusters, particularly for
their use in practical applications. From various processing
methods reported, a versatile synthetic strategy adopted by
many groups is based on thiol-protected synthesis or ‘ligand-
etching’ of pre-formed larger nanoparticles or clusters into sub-
nanometer clusters. Among several ligand-etched systems,
glutathiolated (GSH) Au clusters (Au)n(SG)m remain one of
the most elegant cluster systems owing to their high stability
as well as their well-defined size [9].
While considering the practical applications of fluorescent
metal clusters for biomedical imaging, there are a number
of challenges that remain to be resolved: (a) very low
fluorescence quantum efficiency of thiol-protected clusters, of
the order of ∼10−3–10−5, which is practically insignificant
compared to fluorescent dyes or QDs [7], (b) the monolayer
of the GSH tri-peptide ligand shell bonded to an Au core
by Au–S linkage undergoes fast enzymatic degradation while
interacting with cellular systems leading to loss of cluster
identity and fluorescence, (c) the stability of monolayer-
protected clusters and hence their fluorescence properties are
sensitive to a wide range of pH conditions that are encountered
during bioconjugation reaction protocols and interaction with
cell membrane, endosomes or lysosomes [10], (d) stability
of clusters being highly sensitive to the nature of the surface
ligand (shell), any surface derivatization with biomolecules
such as antibodies, peptides or small molecules may impair
the fluorescence properties and (e) toxicity of metallic clusters
and its associated ligands in biological systems is least
evaluated [11]. In effect, the biomedical application of Au
clusters demands a new set of experiments towards optimizing
the above listed parameters of biological importance, apart
from the challenges posed by its synthesis. In this direction,
recently, Xie et al have reported an important alternative
method of synthesizing fluorescent Au25 NCs (∼0.8 nm)
having a fluorescence QE of ∼6% using BSA as a reductant
as well as a stabilizing agent [12]. Proteins like BSA are stable
against biochemical degradation due to its rich and complex
architecture constituted by repeated units of amino acids like
cysteine, tyrosine and tryptophan [13]. Further, Lin et al have
shown that fluorescent Au clusters can be used for optical
imaging of cells [14].
In the current investigation, we show the possibility
of using BSA-stabilized Au clusters for one of the most
demanding requirements of oncology; ‘single-cell-targeted
imaging’-based cancer detection at an early stage. In
this context, the challenges of using fluorescent metal
nanoclusters for cancer imaging are twofold: (a) maintaining
the fluorescence properties of ligand-sensitive clusters during
the bioconjugation reaction involving different pH conditions
and repeated purification steps and (b) the adverse effects of
the protective ligand, namely BSA, towards competitive non-
specific uptake by the cells. Considering this, Au cluster–
BSA conjugates having very high concentrations of BSA
(∼50 mg ml−1) [12] are not favorable for targeted delivery
because of the dominant role of protein, leading to non-specific
uptake by the cells. In this report, we address both these issues
by using a combination of a green-chemical reducing agent,
vitamin-C, and a low concentration of BSA for the synthesis
of highly fluorescent Au NCs with bright red fluorescence in
the NIR range and surface derivatized with molecular targeting
ligands, namely folic acid (FA) for target-specific detection of
cancer. To the best of our knowledge, this is the first report
showing molecular-receptor-based targeted imaging of cancer
using fluorescent Au nanoclusters (Au NCs) stabilized in BSA.
2. Experimental: materials and methods
2.1. Nanocluster synthesis
All reactions were performed in aqueous medium at room
temperature. In a typical synthesis, 10 mM aqueous solution
of HAuCl4 (Spectrochem PVT Ltd, Mumbai) was reacted with
∼20 mg ml−1 BSA (Sigma Aldrich, USA) under vigorous
stirring at 37 ◦C. To this solution of Au (I)–BSA complex,
∼1 μM total concentration of ascorbic acid was added drop-
wise at a rate of ∼4 μl min−1 followed by the drop-wise
addition of ∼1 M NaOH (Qualigens, India) to trigger the
reduction of BSA-encapsulated Au precursor by ascorbic
acid. This solution was continuously stirred at 37 ◦C for
∼6 h. During this period, the color of the colloid gradually
changed, from transparent to dark yellowish brown and the
red fluorescence emission indicated the nucleation of Au
nanoclusters.
2.2. Bioconjugation of Aun–BSA nanoclusters with folic
acid (FA)
Aun–BSA clusters were conjugated with folic acid (FA) using
a zero-length cross-linker 1-ethyl-3-[3-dimethylaminopropyl]
carbodiimide hydrochloride (EDC). FA was activated to
become amine-reactive by linking with EDC. Typically,
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∼25 mg EDC (Sigma Aldrich, USA) was added to 10 mg of
FA (Sigma Aldrich, USA) in 500 μl PBS (136.9 mM NaCl,
2.68 mM KCl, 8.1 mM Na2HPO4, 1.47 mM KH2PO4, pH
7.4). After 5 min of incubation at room temperature with
probe sonication, the solution was added to 150 mg of Au–
BSA NCs dissolved in 3 ml PBS. After 2 h of incubation
at room temperature with stirring, the pH of the reaction
mixture was adjusted to ∼9 and promptly passed through a
desalting column (Zeba Desalt Spin Columns provided by
Thermo Scientific, India). Alkalization of the reaction mixture
was necessary for the complete separation of free folate from
the conjugate [15]. Successful conjugation of FA to Au–
BSA clusters was confirmed by FTIR and UV–vis absorption
spectroscopy. The conjugated clusters are hereafter referred to
as Au–BSA–FA NCs.
2.3. Nanocluster characterization
The nanoclusters’ size determination was done using a JEOL
3010 model transmission electron microscope. Atomic force
microscopy (AFM), JEOL JSPM-5200, was also used to obtain
the size and morphology of the colloidal samples spray-
coated over an atomically flat mica substrate. The binding
energy of Au–BSA and Au–BSA–FA NCs was determined
by x-ray photoelectron spectroscopy which is an ESCA probe
TPD system with integrated x-ray source. Fourier-transform
infrared spectra of samples supported on KBr pellets were
recorded using a Perkin Elmer Spectrum RX1 for evaluating
the encapsulation of Au NCs by BSA and conjugation of FA
with Au–BSA NCs. UV–vis absorption spectra of BSA, Au–
BSA, FA and Au–BSA–FA NCs were recorded using a UV-
1700 Pharma Spec UV–vis spectrophotometer. Concentration
of BSA present in the final washed product was estimated
from the standard linear curve. Luminescence emission
and excitation spectra of Au–BSA–FA clusters, dissolved in
aqueous solution, were recorded at room temperature, using
a HORIBA JOBIN-YVON Fluoromax 4 spectrofluorometer
with excitation and emission slits at 5 nm with appropriate
filters for removing the second-order diffraction peaks. Near-
infrared imaging of Au–BSA–FA NCs were recorded in cell-
free phantom samples prepared by pelletizing lyophilized
powder into circular discs of thickness ∼10 mm and imaged
using a Kodak In vivo-FX Multispectral Imaging Station. The
samples were excited at 650 nm (±5 nm) and emission was
recorded using the 700–750 nm band-pass emission filter at
the detector side for 30 s integration time.
2.4. Fluorescence quantum efficiency
Fluorescence quantum efficiencies (QE) of Au–BSA and Au–
BSA–FA NCs were measured by a comparative method as
reported earlier [7]. The QE of a sample (QES) is derived
from the equation QES = (IS × QER)/IR, where IS is the
integrated emission intensity of the sample; QER and IR are
the QE and integrated emission intensity of the reference
sample, respectively. For direct comparison with earlier
reports, we used the same fluorescence reference sample,
fluorescein (QE ∼ 0.95), in our experiments. Optical densities
of both the test sample and reference were adjusted to 0.1
at their corresponding excitation peak maximum, 569 nm
for Au NCs and 480 nm for fluorescein. Optical density
and fluorescence intensity were recorded under identical
instrument settings. Since we used the same solvent (water)
for both the test and reference samples, the correction factor
for the refractive index of the solvent was found insignificant
in the calculation. For each sample, the optical density
was recorded using a UV-1700 Pharma Spec. UV–vis
spectrophotometer and the corresponding photoluminescence
spectrum was recorded using a HORIBA JOBIN-YVON
Fluoromax 4 spectrofluorometer.
2.5. Cell line experiments
2.5.1. MTT cell viability assay. Primary endothelial
cells are most suitable for toxicity analysis [16], because
nanoparticles will be first encountered by the endothelial
system after i.v. injection. Human umbilical vein endothelial
cells (HUVEC) were isolated from umbilical veins of healthy
volunteers, as per the protocol approved by the clinical ethics
committee of the Institute. They were propagated for at
least three population doublings before toxicity studies in
Iscove’s Modified Dulbecco’s Medium containing 20% FBS
and 50 IU ml−1 penicillin. FR+ve oral carcinoma KB cells and
FR−ve lung cancer A549 cells were provided by the National
Center for Cell Sciences, Pune, India. RPMI 1640 medium
without and with FA (Sigma Aldrich, USA) were used for KB
and A549, respectively. All the media were supplemented with
10% FBS (Gibco, USA) and 50 IU ml−1 penicillin (Gibco,
USA) 50 IU ml−1 streptomycin (Gibco, USA). Cells were
cultivated in the medium at 37 ◦C in a humidified environment
of 5% CO2. KB and A549 cells were trypsinized and seeded
at a density of 5 × 103 (24 h study) into a 96-well tissue-
culture plate. After 24 h old medium was discarded followed
by replacement with media containing various concentrations
(20, 80, 150, 300 and 500 μg ml−1) of Au–BSA and Au–
BSA–FA NCs. Negative controls were replaced with fresh
10% FBS-containing media whereas Triton X100 (1%) was
added in the positive control. Triplicates were set up for each
sample concentration, negative and positive control. After
24 h incubation the cultured cells were assayed for cell
viability with MTT (Sigma). MTT stock solution (5 mg ml−1)
supplemented with 100 μl of serum-free medium was added
into each well. After 4 h of incubation, the culture medium
was removed and the purple crystals were dissolved in 110 μl
of the solubilization buffer (10% Triton X100 and 0.1 N HCl
in isopropanol). The optical density values at 570 nm were
measured using the microplate reader (Biotex Power Wave XS
Model).
2.5.2. Measurement of intracellular ROS by flow cytometry.
Intracellular accumulation of reactive oxygen species (ROS)
was determined with dichlorofluorescein-di-acetate (DCFH-
dA, M/S Invitrogen). This nonfluorescent compound accu-
mulates within cells upon de-acetylation. DCFH then reacts
with ROS to form fluorescent 2,7-dichlorofluorescein (DCF).
KB cells were trypsinized and seeded at a density of 2 ×
105 cells/well into 6-well tissue-culture plates. After 12 h, old
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medium was discarded followed by replacement with medium
containing 500 μg ml−1 of Au–BSA–FA NCs. Negative con-
trols were replaced with fresh 10% FBS-containing medium
and 500 μg ml−1 H2O2 was added in the positive control. After
12 h of incubation at 37 ◦C, cells were washed with PBS (pH
7.4) three times and incubated with 30 μM of DCFH-dA (dis-
solved in 100% ethanol, filter sterilized) at 37 ◦C for 30 min.
The cells were then harvested with trypsin. The intensity of flu-
orescence was detected by flow cytometry (BDFACSAria™ II)
with an excitation filter of 488 nm and a band-pass emission
filter of 530 ± 15 nm.
2.5.3. Cellular uptake studies by fluorescent microscopy. For
FR-targeted cancer imaging, oral carcinoma KB cells and
breast adenocarcinoma MCF-7 cells were up-regulated for the
folate receptors by growing in folate-free RPMI 1640 medium
at 37 ◦C with 5% CO2 for 3 weeks. As negative controls,
the FR−ve cancer cell line A549 was cultivated under similar
conditions in RPMI 1640 medium supplemented with 10%
serum. Further, FR-depressed KB cells (FRd) were also used
to confirm the FR-targeted delivery of QDs. For this, 100-
fold molar excess of free FA was added to the cell suspension
10 min prior to the addition of Au–BSA–FA conjugates. For
imaging study, cells were trypsinized and seeded on 13 mm
glass cover slips placed inside 24-well tissue-culture plates at
a seeding density of 1 × 103 cells/cover slip. After 23 h,
the adherent cells were washed twice with PBS followed
by replacement of media containing bare and FA-conjugated
BSA encapsulated Au NCs with 1 mg ml−1 concentration and
incubated for 2 h at 37 ◦C. Cells were then washed one time
with PBS (300 μl/well), fixed with 2% paraformaldehyde
for 20 min and mounted with the mounting medium. For
DAPI staining of the nucleus ∼500 μl half diluted DAPI
(Sigma Aldrich, India) from the main stock concentration of
500 μg ml−1 was incubated for 7–8 min with the cells. After
PBS washing, the cover slips were mounted on glass slides
with DPX mountant and the fixed cells were imaged on an
Olympus BX-51 fluorescent microscope equipped with a color
CCD camera (Model DP71) and 60× oil immersion objectives.
NC fluorescence was detected using band-pass excitation and
emission filters (BP 480–550 nm excitation, 590 nm emission
and 570 nm dichromatic mirror).
2.5.4. Nanocluster uptake studies by spectrofluorimetry. Oral
cancer cell, KB, breast cancer MCF-7 cells and lung cancer
A549 cells from a confluent flask were seeded at a density
of 1 × 106 cells per well in a 6-well plate. RPMI FA-
free medium supplemented with 10% FBS and 50 IU ml−1
antibiotics was used for culturing the cells. After 24 h of
incubation in a humidified atmosphere of 5% CO2 at 37 ◦C
old medium was discarded and new medium containing FA-
conjugated and-unconjugated Au–BSA NCs were added. The
cells were incubated in this medium for 4 h. Cells without any
nanoconjugates and PBS were used as the controls. The cells
were washed twice with PBS and trypsinized and a cell pellet
was collected by centrifuging at 1500 rpm for 5 min. The cells
were lysed with 10 μl cell-lyses buffer containing protease
inhibitor. The lysed cells were re-suspended in 1 ml PBS and
centrifuged at 10 000 rpm for 10 min. The supernatant was
collected and the volume was made up to 3 ml using PBS. The
integrated fluorescence emission intensity of both Au–BSA
and Au–BSA–FA NCs from cell lysate were measured using
a HORIBA JOBIN-YVON spectrofluorimeter. The relative
emission intensities at 674 nm from KB, MCF-7 and A549
cell-lysate were plotted.
3. Results and discussion
3.1. Nanocluster synthesis
According to the main objective of this work, to prepare bio-
conjugated fluorescent Aun nanoclusters (NCs) for receptor-
targeted cancer imaging, the synthesis and bioconjugation
protocols were optimized considering the following factors:
(a) minimum use of cluster-stabilizing protein, BSA, which
can cause non-specific uptake of Au clusters by the cells and
(b) maintenance of cluster fluorescence over a wide range of
pH from 4 to 9, which includes cell-culture pH ∼ 7.4 and
intracellular lysosomal pH ∼ 4–5. Our initial cell targeting
experiments with Au clusters containing high concentrations
of BSA (50 mg ml−1) [12] were found unsuccessful due to
the non-specific uptake of nanoconjugates even without any
folate targeting ligand on the surface of nanoclusters or con-
trol cells having no or depressed folate receptors on the mem-
brane. Accordingly, in the subsequent experiments, we have
reduced the BSA concentration to ∼20 mg ml−1 and a green-
chemical reducing agent, ascorbic acid (vitamin-C), was used
to trigger the formation of nanoclusters at a low BSA concen-
tration. The role of ascorbic acid was evident from the fact that,
with only 20 mg ml−1 BSA in the reaction medium, we have
not observed the formation of Au clusters even after 24–48 h
of reaction at 37 ◦C. In contrast, with the controlled addition
of ascorbic acid, the colloidal system slowly turned from pale
yellowish to brown after ∼3 h of reaction and started show-
ing a typical bright fluorescence related to Au25 clusters [12].
Further, it was noted that, when the concentration of ascorbic
acid exceeded 1 μM, or the rate of addition was accelerated
>4 μl min−1, uncontrolled precipitation occurred of larger Au
nanoparticles of ∼20 nm showing surface plasmon resonance
(absorbance) at ∼520 nm with no fluorescence. It is also to
be mentioned that we had to readjust the concentration of the
reducing agent within the range of 5–10%, when the source of
supply of HAuCl4 or BSA was changed, indicating the sensi-
tivity of reaction parameters.
3.2. Characterization
3.2.1. Folic acid conjugation. Bioconjugation of FA
with fluorescent Au clusters is an important aspect of
the present work. Folic acid is a water-soluble vitamin
(B11) which is taken up by the cells through folate
receptor (FR)-mediated endocytosis, namely potocytosis,
which is especially important during the periods of rapid
cell division and growth as in the case of cancer [17].
FR is a glycosylphosphatidylinositol (GPI)-anchored high-
affinity membrane protein, over-expressed in a number of
human tumors including ovarian cancer and squamous cell
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Figure 1. Bioconjugation scheme for BSA-stabilized Au cluster:
step 1: FA is reacted with EDC to form an amine-reactive
O-acylisourea intermediate. Step 2: O-acylisourea intermediate
reacts with primary amines on the surface of BSA to form
Au–BSA–FA conjugates.
carcinoma. The normal tissue distribution of the folate receptor
is highly restricted, making it a useful marker for targeted
drug delivery to tumors. FA retains its receptor binding
affinity when covalently linked to the drug/contrast agent
through its gamma-carboxyl group. FA-based targeting is
attractive over antibodies because of its smaller size, lack of
immunogenicity, ready availability, low cost and relatively
easy bioconjugation chemistry [18–20]. Considering these
aspects, we chose FA to conjugate with Au–BSA NCs for
targeting the cancer cells that over-express FR, called FR+ve
cells. Since the molecular surface of BSA has several amine
groups and FA has carboxylic groups, direct conjugation
through amine–carboxylate linkage was possible. Figure 1
depicts the schematic diagram of the reaction sequence used
for the bioconjugation reaction. First, FA is ‘activated’
into an amine-reactive succinimide ester using a well-known
carbodiimide cross-linker (EDC) which reacts with a γ -
COOH group of FA at pH 4.5, forming an amine-reactive
O-acylisourea intermediate which readily reacts with primary
amines in BSA at pH 7.4. One of the major challenges in
this reaction sequence was to protect Au clusters from losing
their cluster character due to the reaction of BSA with FA. The
molecular nature of Au clusters having only a few tens of atoms
makes its physico-chemical stability and properties highly
sensitive to the surface ligand and hence the introduction of
FA to the protective BSA shell can lead to changes in the
cluster properties, such as fluorescence emission and binding
energy. At the same time, an optimum concentration of FA was
needed to achieve efficient cell targeting. Hence, a ‘trade-off’
between the stability of the Au core to cell targeting efficacy
and fluorescence was achieved by optimizing the FA/BSA
ratio to ∼0.02 (w/w). The minimum concentration of FA
needed for effective cell targeting was empirically identified
by varying the concentration ratio of FA/BSA (w/w) from
0.01 to 0.1. From the experimental results (fluorescence and
cell targeting efficacy), the FA/BSA ratio of ∼0.02 (w/w) has
been optimized and maintained for all Au–BSA–FA samples
discussed hereafter, unless otherwise specified.
3.2.2. Atomic force microscopy and transmission electron
microscopy of Au–BSA–FA conjugates. Atomic force
microscopy (AFM) was used to image the morphology of
Au–BSA–FA conjugates, formed by spray-coating of the
colloidal sample as a thin film on an atomically flat mica
substrate. Figure 2(a) shows the AFM image of Au–BSA–
FA conjugates where the digitally enlarged part (figure 2(a),
inset) shows relatively larger conjugates of size ∼8.5 nm,
indicating the formation of nanoparticulates of Au–BSA–FA.
Essentially, the sub-nanometer-sized molecular Au clusters
are embedded within these self-assembled protein aggregates,
but they retained the characteristic cluster fluorescence, as
observed under the fluorescence microscopic imaging of the
same film, shown in figure 2(b). Further, in TEM imaging
(figure 2(c)) individual nanoclusters (marked by arrows) of size
∼1 nm were found distributed all throughout the imaging area.
Relatively large (8 nm) aggregates of Au–BSA–FA conjugates
(marked by circles) could also be seen.
3.2.3. X-ray photoelectron spectroscopy. X-ray photoemi-
ssion spectra indicating the binding energy of the Au core of
Figure 2. (a) AFM image of Au–BSA–FA cluster conjugates recorded from a film formed over atomically flat mica substrate, Inset: digitally
enlarged image of relatively larger, spherical aggregates of size ∼8.5 nm, (b) fluorescent image of the aggregated clusters from the same film,
(c) TEM image of nanoclusters; aggregates are marked by circles while separated Au–BSA–FA clusters are marked by arrows, (d) XPS data
showing binding energy of Au–BSA and Au–BSA–FA.
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the conjugates are shown in figure 2(d). The observed binding
energy values for optimized conjugates show Au 4f7/2 ∼
83.97 eV and Au 4f5/2 ∼ 87.768 eV, which correlate very
well with the metallic Au (0) [25, 26]. However, it is
interesting to note that, when conjugated with FA at a higher
concentration of FA/BSA  0.02, the XPS data exhibits a
slight shift in the binding energy, indicating direct electron
transfer from FA to Au core or changes in the BSA–Au ligand–
core interactions. We considered this as the maximum limiting
concentration of the targeting ligand FA, above which the core–
ligand interactions leading to changes in the physicochemical
characteristics of Au clusters occur. Although detailed XPS
analysis will be needed to understand the exact nature of such
interactions, for the practical purpose of cancer cell targeting,
this unfavorable condition was avoided by maintaining the
FA/BSA concentration well below 0.02 where the Au core
retained its Au0 metallic status together with good fluorescence
efficiency, ∼5.7%, and cell targeting efficacy. Essentially,
the XPS studies reveal the importance of understanding the
core–ligand interactions while bioconjugating the nanocluster
systems and the need to optimize ligand concentration for
retaining the cluster properties.
3.2.4. Fourier-transform infrared spectroscopy. The
bioconjugation scheme was analytically followed using
Fourier-transform infrared (FTIR) spectroscopy. Figure 3
shows the FTIR spectrum of BSA, Au–BSA, FA and Au–
BSA–FA NC conjugates, respectively. The characteristic
amide I band of BSA can be seen at 1654 cm−1 as expected
for a protein with a high proportion of α-helix. The band
appearing at 1545.00 cm−1 can be attributed to strong primary
amine scissoring, whereas the band centered at 3435.98 cm−1
can be attributed to primary amines. The band appearing at
2958.79 cm−1 corresponds to C–H vibration and the broad
band at 701.65 cm−1 can be attributed to −NH2 and −NH
wagging [21]. In the final conjugate of Au–BSA–FA NCs, all
the characteristic vibrational modes associated with FA, such
as C–H stretching at 2943.00 cm−1 and aromatic ring stretch
of the pyridine and p-amino benzoic acid moieties in the range
of 1476–1695 cm−1, can be clearly seen. Peaks at 1336.00 and
912.00 cm−1 show the presence of aromatic C–H in-plane and
out-of-plane bending, respectively [22]. The line broadening
appearing over 1652–1350 cm−1 is indicative of the covalent
linkage of FA with BSA.
3.2.5. UV–vis absorption spectroscopy. The synthesis
and bioconjugation steps were also followed using UV–vis
spectroscopy. The absorption spectra of BSA and Au–BSA
NCs are shown in figure 4(a) while that of FA and Au–BSA–
FA NC conjugates are depicted in figure 4(b), respectively.
Au–BSA NCs show a prominent absorption at 280 nm which
correlates with the classic absorbance of aromatic amino acids,
mainly tryptophan and tyrosine [23]. The additional new
absorbance seen over the 300–450 nm region can be attributed
to the HOMO–LUMO electronic transition within Au clusters,
which is not observed in the case of pure BSA. From the
absorption spectra, the concentration of BSA is estimated to
be ∼17.5 mg ml−1 in the final Au–BSA system formed by
Figure 3. FTIR spectra of (a) BSA, (b) Au–BSA, (c) FA and
(d) Au–BSA–FA samples, recorded in KBr-supported pellets. The
characteristic vibration bands related to BSA and FA can be clearly
seen in the final conjugates of Au–BSA–FA.
taking ∼20 mg ml−1 of BSA in solution. Accordingly, FA-
conjugated samples with different FA to BSA ratios were
prepared and a representative UV–vis data (figure 4(b)) of Au–
BSA–FA with FA/BSA ratio of 0.02 (w/w) show the presence
of characteristic absorption features of FA in the 250–280 and
320–400 nm ranges [24] with a distinct absorption hump at
320–400 nm (marked by the circle) which exemplifies the
HOMO–LUMO transition of Au clusters embedded within the
conjugates.
3.2.6. Photoluminescence properties. Photoluminescence
excitation and emission spectra of Au–BSA–FA conjugates
dissolved in water and recorded at room temperature are
depicted in figure 5(a). The concentration of the conjugate is
maintained at 1 mg ml−1. The photoluminescence excitation
spectrum recorded for red emission at 674 nm exhibited double
maxima at 530 and 569 nm, which correlate well with the
typical Au25 fluorescence related to HOMO–LUMO electronic
transitions as reported earlier [12]. When excited using 530 or
569 nm light, the sample showed broad fluorescence spectra
with a peak maximum at 674 nm, with the spectral edge
extending to the near-infrared region (NIR) up to 800 nm.
From the photoluminescence spectra, it is clearly evident
that this fluorescence is characteristic of Au25 clusters and
not Au8, which gives blue fluorescence due to interband
transitions [27]. The origin of photoluminescence from the
Au NCs has been discussed by several authors using a solid-
state model for the electronic structure and relaxation of
6
Nanotechnology 21 (2010) 055103 A Retnakumari et al
Figure 4. UV–vis absorption spectra of (a) BSA and Au–BSA, (b) FA and FA-conjugated Au–BSA. The region in the circle shows an
additional absorption hump indicating the presence of Au clusters in Au–BSA–FA conjugates.
Figure 5. (a) Excitation and emission spectrum of Au clusters, (b) changes in the fluorescence intensity of Au clusters with increase in FA
conjugation indicating core–ligand interactions, (c) photograph of Au–BSA NCs under white light illumination, (d) UV 365 nm excitation and
(e1)–(e3) NIR imaging of phantom samples under 630 nm excitation and emission at 700 nm; 10 s integration; 750 nm, 1 s integration and
790 nm with 30 s integration time.
the clusters [8, 9, 28, 29]. In bulk phase, metals do not
have energy bandgaps. However, for both semiconductor
and (transition-) metal NPs, one interesting property is the
appearance of an energy bandgap with decreasing particle
dimensions [30]. Luminescence studies on neutral metal
clusters show the observation of photoluminescence near
440 nm for <5 nm-sized gold particles after excitation at
230 nm. The origin of this photoluminescence was attributed
to sp to d-band transitions which are high-energy transitions
analogous to intraband transitions in bulk gold. It was expected
that the photoluminescence mechanism for these NCs in the
NIR range would involve low-energy transitions across the
HOMO–LUMO gap as depicted (figure 6(b)). Recently,
Whetten et al [7] and Murray et al [29] separately reported
the observation of NIR to visible fluorescence from nanosized
Au NPs of size <1.8 nm and interpreted the NIR emission is
due to HOMO–LUMO electronic transition of lower energy
than that of the d–sp interband transition whereas the visible
emission was ascribed to the interband transitions between the
filled 5d10 band and the 6sp1 conduction band.
Considering the specific objective of targeted cancer
imaging using Au nanoclusters, our focus was to synthesize
clusters showing bright and stable fluorescence in the NIR
range, particularly after bioconjugation with the targeting
ligand and delivery into intracellular regions, where the
lysosomal pH (∼4.5–5) may affect the cluster fluorescence.
Under the present synthesis method, the Au–BSA conjugates
have shown excellent fluorescence stability over a wide range
7
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Figure 6. MTT cell viability assay on (a) primary HUVEC cells,
(b) FR+ve KB cells and (c) FR−ve A549 cells in a 24 h study.
Concentration used for both Au–BSA and Au–BSA–FA samples was
500 μg ml−1, positive control: Triton X100, negative control: cells
without nanoclusters.
of pH from 4 to 14. However, we have found that, during
bioconjugation, with increasing FA concentration above the
FA/BSA ratio >0.02, the fluorescence intensity of clusters
gradually reduced, as shown in figure 5(b). Apparently,
although BSA was acting as a strong stabilizing agent, the
radiative transitions within the Au core were found to be
affected due to FA conjugation. Similar observations were
reported in thiol-protected Au clusters, (Au)nSGm , where the
presence of ligands on the surface of Au NCs was found
significantly influencing the electronic distribution [31–33].
This strongly suggests that the surface chemistry plays a
vital role in determining the electronic energy structure and
hence the fluorescence characteristics of Au NCs. This
aspect was important for our investigations because it is
quite probable that, during the receptor–ligand interaction or
during the enzymatic activity within the cells, the clusters may
lose their fluorescence due to the modification or cleavage
of Au–BSA bonds. Considering these issues, and from
the empirical observations, we have optimized the minimum
concentration of the FA/BSA ratio that is needed to maintain
better fluorescence efficiency and cell targeting capability as
∼0.02. At this ratio, the quantum efficiency (QE) of Au–
BSA–FA was found ∼5.7% which is only marginally lower
than ∼6.0% of unconjugated Au–BSA nanoclusters.
3.2.7. Phantom imaging at near-infrared region. For non-
invasive in vivo fluorescent imaging, near-infrared (NIR)
excitation and emission characteristics are an essential
requirement, because of favorable tissue-optical properties in
this range. Accordingly, we tested the possibility of imaging
the bioconjugated Au clusters under an NIR window (700–
800 nm) using a Kodak multispectral imaging station fitted
with an NIR-intensified CCD camera. Figure 5(c) shows
the white light image of the colloidal sample and figure 5(d)
shows the fluorescence emission from the sample under UV
excitation. The same sample was lyophilized and pelletized
into phantom samples and imaged under three different NIR
emission ranges. Figures 5 (e1), (e2) and (e3), respectively,
show images recorded using 700 ± 10 nm, 750 ± 10 nm
and 790 ± 10 nm emission filters under 630 nm excitation.
Integration time was kept at 10 s for 700 and 750 nm windows
whereas 30 s was kept for the 790 nm window. In all
three imaging conditions, the samples showed bright NIR
fluorescence, suggesting that these fluorescent Au clusters can
be a promising choice for in vivo imaging applications.
3.3. Cell line experiments
For the development of a contrast agent for biomedical
imaging applications, one of the most important screening
criteria is its toxicity effects on biological systems. This
is particularly important for nanoparticles because of its
comparable size with biomacromolecules such as proteins or
enzymes, leading to enhanced interactions. Although several
nanoparticulate systems such as QDs were proposed to be
excellent materials for contrast imaging, they were later found
unsuitable for in vivo use due to the toxicity associated with
heavy metals [34]. Hence, we evaluated the cytotoxicity of
Au–BSA and Au–BSA–FA NCs on human primary endothelial
cells derived from the umbilical cord (HUVEC) as well as
two cancer cell lines having different levels of folate receptor
expression: FR+ve squamous cell carcinoma (KB) and FR−ve
lung carcinoma A549.
3.3.1. MTT assay. Different concentrations (20–500 μg ml−1)
of Au–BSA and Au–BSA–FA NCs were treated with ∼5×103
cells for 24 h. Negative controls were replaced with fresh 10%
FBS-containing media whereas Triton X100 (1%) was added
to the positive control. Triplicates were set up for each sample
concentrations as well as negative and positive controls. After
24 h of incubation, the cultured cells were assayed for cell vi-
ability with an MTT assay. The results are shown in figure 6.
It is interesting to note that, even up to relatively high concen-
trations of ∼500 μg ml−1, both primary and cancer cells did
not show any kind of toxicity due to their interaction with nan-
oclusters. The cells remained ∼100% viable even after 24 h
of incubation which indicates the non-cytotoxicity of Au NCs.
We believe that the protective coat of BSA must be having a
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Figure 7. Intracellular ROS generation assay using dichlorofluorescein-di-acetate (DCFH-dA) shows the % of cells generating ROS in:
(a1)–(a2) negative control cells without nanoclusters, (b1)–(b2) positive control of 500 μg ml−1 H2O2 and (c1)–(c2) cells treated with
500 μg ml−1 of Au–BSA–FA conjugates.
significant role in maintaining the bio-friendly nature of nan-
oclusters.
3.3.2. Intracellular ROS stress by flow cytometry. In addition
to the MTT assay, which registers only the mitochondrial
activity of cells or viability, we have also evaluated the reactive
oxygen stress, if any, caused by the interaction of cells with
Au NCs. Reactive oxygen species (ROS) was found to be
one primary reason for toxicity by other nanomaterials [35].
Studies were carried out by monitoring the production of a
fluorescent compound, 2,7-dichlorofluorescein (DCF), by the
ROS species and counting those cells by flow cytometry.
Untreated cells were used as negative control while cells
with 500 μg ml of H2O2 were taken as positive control.
Figures 7(a1)–(a2) depict the intracellular ROS concentration
in untreated cells whereas figures 7(b1)–(b2) show ROS
detected in the positive control (H2O2) which is ∼53.5% of
the total cell count. In contrast, Au–BSA–FA conjugate-treated
cells show practically no ROS stress in the total population
as shown in figure 7(c1)–(c2). Most interestingly, the level of
ROS from the cells treated with Au–BSA–FA was found to be
even less (0.4%) than that of negative control (4.7%). This is
possibly due to the fact that proteins and vitamins like folic
acid can scavenge ROS formed in the cells [36, 37] and hence
protect the cells. In effect, this implies that the Au–BSA–FA
NCs are not only non-toxic but also protect the cells from other
external stresses.
3.3.3. Receptor-specific detection of cancer using Au–
BSA–FA cluster conjugates. The possibility of molecular-
receptor-targeted optical detection of cancer using Au–BSA–
FA conjugates was tested on FR+ve KB cells with FR−ve A549
cells, FR-depressed (FRd) KB cells and FR+ve KB cells treated
with unconjugated Au–BSA clusters as negative controls.
Target specificity of FA-conjugated Au–BSA NCs was also
tested in another cell line, breast adenocarcinoma MCF-7,
which also over-expresses folate receptors but relatively less
in comparison with oral cancer KB cells [39]. Prior to
the targeting studies, in a separate set of experiments, we
have characterized the folate expression level on KB cells
using functional AFM imaging wherein FA-functionalized
silicon tips were used to image the FR ligands from
cell membranes [38]. The AFM images clearly showed
significantly higher levels of FR expression on KB cells
compared to the negative control and we used the same
batch of cells for the present study. The concentration of
nanoconjugates was maintained at 1.0 mg ml−1 in 250 μl of
medium containing ∼1000 cells, incubated for 2–24 h, before
fixing onto the glass slides for imaging. Figures 8(a1)–(a2)
represent the bright-field and dark-field fluorescence images
of FR−ve A549 cells treated with Au–BSA–FA conjugates
after 24 h of incubation (excitation: 480–550 nm, emission:
590 nm). It can be seen that, even after an extended duration
of incubation with relatively high concentration of conjugates,
no significant cellular uptake or staining of cell membrane
could be seen. Some of the red-emitting clusters were
found non-specifically located in the glass slide but not as a
specific stain over the cell membrane. As another control,
we used FR-depressed KB cells obtained by pre-treating the
FR+ve cells with 100 μM concentration of free FA. This
way the FR receptors on cell membrane will be preoccupied
with potocytosis and no active FR-mediated endocytosis will
be possible on further treatment with the FA-conjugated
clusters. This is evident from figures 8(b1)–(b2) that show
the images of FRd KB cells incubated with Au–BSA–FA
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Figure 8. Fluorescent microscopic images showing interaction of Au–BSA–FA NCs with different types of cell lines: (a1)–(a2) FR−ve lung
carcinoma A549, (b1)–(b2) FR-depressed oral cell carcinoma, KB, (c1)–(c2) FR+ve KB cells with unconjugated Au clusters, (d1)–(d2) FR+ve
KB cells with FA-conjugated Au clusters at 2 h, (e1)–(e2) 4 h and (f1)–(f2) 24 h of incubation.
for 24 h. There appeared to be no significant staining or
cellular uptake suggesting no FA-mediated process and the
non-specific uptake of Au–BSA–FA conjugates is insignificant
even at relatively high concentration of conjugates (1 mg ml−1
for 1000 cells). This is further examined by treating
the FR+ve cells with unconjugated Au–BSA nanoclusters
(figures 8(c1)–(c2)), which also showed no specific attachment
of nanoclusters to the FR+ve cell.
In contrast to the control experiments, the nature of
interaction of FA-conjugated Au–BSA samples changed quite
significantly when incubated with FR+ve KB cells. In
figures 8(d1)–(d2), KB cells treated with Au–BSA–FA at
2 h are shown. Interestingly, as early as 2 h, large
numbers of red-emitting Au–BSA–FA conjugates were found
specifically attaching to the cell membrane of FR+ve KB
cells. Relatively larger sized nano-aggregates, marked by
white arrows, were accumulated mostly on the cell membrane
while the solubilized clusters stain the whole cell, rendering
a red fluorescent stain of the whole cell. With a longer
incubation time of 4 h (figures 8(e1)–(e2)), the concentration
of aggregated nanoclusters on the cell membrane was found
reduced with an increase in fluorescence at the intracellular
region. After 24 h, no aggregated nanoconjugates were seen
on the cell membrane but found completely internalized in
the cytosol. To differentiate the nucleus from cytosol, DAPI
staining was carried out and the red emission (true-color
imaging) from Au nanoclusters within the cytosol can be
clearly seen. These results clearly suggest that the Au cluster
conjugates were specifically taken up by the FR+ve cells and
the fluorescence intensity of internalized clusters remained
intact, indicating the maintenance of cluster identity within
the intracellular regions. In breast adenocarcinoma cells,
MCF-7, the expression level of folate receptors is reported
to be relatively low compared to that of KB cells [39]. We
have tested corresponding relative changes, if any, in the FR-
mediated uptake of nanoclusters in MCF-7 compared to KB
cells by incubating the same concentration of FA-unconjugated
and-conjugated Au–BSA NCs with MCF-7 and KB cells under
identical culture conditions. In figure 9, it can be seen
that, without any FA, the BSA–Au did not show any specific
attachment to MCF-7 whereas FA-conjugated Au–BSA NCs
showed enhanced uptake leading to red fluorescent staining of
the cell membrane. The relative difference in the uptake was
measured by spectrofluorimetric studies of red fluorescence
from Au clusters present in the cell-lysates of KB, MCF-7
and A549 cells. Cells incubated without any nanoclusters and
PBS were used as the controls. Prior to the experiment, the
unattached nanoconjugates were washed out with PBS and
cells were trypsinized and lysed. In figure 9(c), the emission
intensity at 674 nm of Au–BSA–FA NCs was found higher in
the case of KB cell-lysate. MCF-7 cell-lysate showed relatively
less emission intensity compared to that of KB, but higher than
that of A549. This result further confirms that the Au–BSA–
FA conjugates were taken up by KB and MCF cells through
FR-mediated endocytosis and there were relative changes in
the uptake due to varied expression levels of the receptor. In
effect, this study clearly demonstrates that the fluorescent Au
nanoclusters can be successfully used for molecular-receptor-
specific detection of cancer, at the single cell level, by optical
imaging. Considering the near-infrared emission property and
non-toxicity, the Au-nanocluster-based nanobioprobes will be
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Figure 9. Fluorescent microscopic images showing interaction of Au–BSA NCs with MCF-7 cells: (a1)–(a2) unconjugated Au–BSA NCs
treated with MCF-7 cells for an incubation period of 4 h, (b1)–(b2) Au–BSA–FA NCs treated with MCF-7 cells for 4 h, (c) integrated
fluorescence intensity recorded from cell-lysate after treating with FA-conjugated Au–BSA NCs in KB, MCF-7 and A549 cells.
a better alternative to luminescent quantum dots for in vivo
applications.
4. Conclusion
In summary, a novel bio-friendly fluorescent Au-cluster-based
conjugate capable of specifically targeting molecular receptors
on cancer cell membranes is presented. Aqueous colloidal
formulations of albumin-protein-capped Au NCs of ∼25
atoms showing characteristic NIR fluorescence (600–800 nm)
were synthesized using a simple green-chemical method and
conjugated with a cancer targeting ligand, folic acid. The
quantum efficiency of Au–BSA clusters was found to be ∼6%,
with marginal reduction after folic acid conjugation as 5.7%.
The concentration of FA and Au–BSA were optimized by
considering a trade-off between the maintenance of bright
fluorescence together with effective cancer targeting ability
and minimum non-specific cellular uptake. The Au clusters
showed broad fluorescence covering the NIR range, making
it possible to image the clusters under 700–800 nm range
where the tissue blood optical properties are highly favorable
for biomedical imaging. The cytotoxicity studies using cell
viability and ROS analysis suggested that Au NCs are non-
toxic with no adverse effect on cell viability; rather, the
residual ROS within the untreated cells disappeared after
the nanocluster treatment, probably due to the free radical
scavenging effect of the folic acid–protein combination. The
molecular-receptor-targeted cancer detection using Au–BSA–
FA conjugates was demonstrated using FR+ve nasopharyngeal
carcinoma cells, KB, wherein the nanoclusters specifically
detect the KB cells while leaving the FR−ve and FR-depressed
control cells unstained. In the case of FA-conjugated samples,
the membrane bound clusters were found internalized in a
time-dependent manner suggesting FR-mediated endocytosis.
The nanoclusters were also found maintaining its bright
fluorescence after internalization into cytosol. The bio-friendly
nature, near-infrared fluorescence and receptor specific cancer-
targeting ability of Au clusters makes them an ideal candidate
for optical-imaging-based cancer detection.
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